About Us  |  Contact Us  |  Español
Butler Hospital
Butler Hospital

The WE QUIT Study

We Quit Smoking Research Study

What is the Purpose of The WE QUIT Study?
The aim of the WE QUIT (Women Engaging in Quitting Smoking Together) is to evaluate two smoking cessation treatment programs for women. This study is funded by the National Institutes of Health and conducted by researchers at Butler Hospital who are affiliated with the Alpert Medical School of Brown University.

Eligibility
Women aged 18-65 who smoke at least 10 cigarettes daily, want to quit smoking, and are concerned about gaining weight after quitting may be eligible.

Participation
Participation in the WE QUIT study involves an initial screening appointment to ensure eligibility that includes completion of interviews and questionnaires. Eligible women are then assigned to one of two quit smoking treatment programs. Both treatment programs include one 60-minute individual counseling session, eight weekly 90-minute group counseling sessions, one brief telephone counseling session, and eight weeks of nicotine patches. Counseling and patches are provided at no cost.

All participants are asked to complete interviews and questionnaires during the week before quitting ("pre-quit"), at the end of the counseling sessions, and 1, 3, and 6-months after counseling ends. Participants are compensated up to $175 for full participation in the pre-quit and follow-up appointments.

Individual appointments are scheduled at times that are convenient for you. Weekday evening appointments are available. Group times are chosen based on group members' schedules, typically a weekday evening.

Please call (401) 455-6480 to learn more about WE QUIT and to find out if you are eligible. Or, you may fill out the following form to have the researchers call you. Please provide your name, telephone number, and a good time to reach you in the boxes below. Please do not include any other information. When you are done, press submit. We will contact you soon.

Please include AM or PM

 
 
Health Headlines
Drug Gives 'New Hope' Against Heart Failure, Expert SaysView in a lightbox
Biggest Ever Weekly Rise in Ebola Cases, U.N. Agency SaysView in a lightbox
Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken AmericansView in a lightbox
European MRSA Originated in Sub-Saharan Africa, Study FindsView in a lightbox
'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study FindsView in a lightbox
Butler Hospital
© 2011 Site Index | Disclaimer | Legal Notices